Ortivus’ Year-end Report, January – December 2021

Ortivus is awarded new contracts

Highlights October – December 2021

  • Ortivus was awarded a contract on delivery of equipment to Regions Skånes ambulance organisation. The contract cover Ortivus' solutions MobiMed Monitor and MobiMed Life defibrillators to all of the regions' ambulance vehicles. The order value is estimated to 30 MSEK. The contract duration is 2 years with a possible extension of another 2 years.
  • Ortivus was awarded an additional contract on delivery of semi-automatic and automatic external defibrillators (AEDs) to Region Jönköping County's hospital. The order value is estimated to 4.5 MSEK.
  • Ortivus and Trapeze Group entered into a strategic partnership covering the Australian and New Zealand markets.

Significant events after end of the period

  • Ortivus appoints Viveka Hiort af Ornäs as new CFO and member of the management team.

October – December 2021

  • Net sales amounted to 22.6 (21.9) MSEK.
  • The gross margin increased to 54 (49)%, during the fourth quarter compared to the corresponding period last year.
  • Profit after tax amounted to 1.7 (2.2) MSEK.
  • Earnings after tax per share before and after dilution amounted to 0.04 (0.05) SEK.
  • Operating cash flow amounted to 3.2 (0.4) MSEK.

January – December 2021

  • Net sales amounted to 94.3 (107.6) MSEK. During 2020, the turnover consisted largely of one-off deliveries, which means that the years are not directly comparable.
  • The gross margin increased to 51 (36) %, during the year compared to 2020.
  • Profit after tax amounted to 9.2 (11.3) MSEK.
  • Earnings after tax per share before and after dilution amounted to 0.21 (0.26) SEK.
  • Operating cash flow amounted to 14.7 (11.8) MSEK.
  • The Board of Directors proposes that no dividend be paid for the financial year 2021.
Okt-Dec 2021 Okt-Dec 2020 Jan-Dec 2021 Jan-Dec 2020
Net sales (MSEK) 22.6 21.9 94.3 107.6
Gross margin (%) 54 49 51 36
Operating profit (MSEK) 1.7 2.2 9.3 11.4
Operating margin (%) 8 10 10 11
EBITDA (MSEK) 3.1 2.5 12.7 13.9

Contacts

For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12 000 paramedics in over 2 700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 2.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-02-16 08:30 CET.

Attachments

Ortivus' Year End Report 2021

This entry was posted in . Bookmark the permalink.